Logo image
A Comparison of the Efficacy and Safety of Modified Baerveldt Drainage Implants versus Ahmed Glaucoma Valves After 1 Year of Follow-Up
Journal article   Open access   Peer reviewed

A Comparison of the Efficacy and Safety of Modified Baerveldt Drainage Implants versus Ahmed Glaucoma Valves After 1 Year of Follow-Up

Kristin L Davis, Quinton H Christensen, Joel A VandeLune, Danielle R Pellack, Patrick J Donegan, Matthew D Meyer, Ronak S Singh, Hend M Al-Kaylani, Erin A Boese and Andrew E Pouw
Clinical ophthalmology (Auckland, N.Z.), Vol.20, 588163
07/2026
DOI: 10.2147/OPTH.S588163
PMCID: PMC13356841
PMID: 42438751
url
https://doi.org/10.2147/OPTH.S588163View
Published (Version of record) Open Access

Abstract

Purpose: A modification to the Baerveldt Glaucoma Implant allows for earlier postoperative intraocular pressure (IOP) reduction. The goal of this study was to evaluate the efficacy and safety of this modification (vsBGI) compared to the Ahmed Glaucoma Valve (AGV) out to 1 year of follow-up. Patients and Methods: This retrospective cohort study included 124 eyes from patients aged ≥ 18 years with glaucoma who underwent implantation of vsBGIs or AGVs. Longitudinal outcomes were analyzed using adjusted linear mixed-effects models to account for baseline differences. Kaplan-Meier survival curves were used to compare surgical success. The primary outcomes were IOP and number of medications. Results: A total of 124 eyes were included (62 AGV and 62 vsBGI). Preoperative IOP was found to be significantly higher in the AGV group prior to surgery. At 1 year, median IOP reduction was similar between groups. Kaplan–Meier analysis showed no significant between-group difference under the liberal (≤ 21 mmHg), conservative (≤ 14 mmHg), or individualized target-IOP criteria, whereas the vsBGI group showed higher survival probability at the intermediate threshold criterion (≤ 17 mmHg). The vsBGI group required significantly fewer medications on Day 1. No statistically significant differences in postoperative complication frequency or type were observed between groups. Conclusion: The vsBGI showed broadly comparable 1-year efficacy and safety to the AGV, with similar IOP reduction and surgical survival, fewer early postoperative medications, and comparable visual acuity and adverse event rates.
glaucoma Ahmed glaucoma valve Baerveldt glaucoma implant ventilating mattress suture tube shunt glaucoma surgery

Details

Metrics

2 Record Views
Logo image